Clearside Biomedical 주식 (NASDAQ: CLSD)

에 대한 최신 뉴스 Clearside Biomedical (NASDAQ:CLSD) 주식

Clearside Biomedical

Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.

Clearside Biomedical, Inc. - Common Stock

Clearside Biomedical Inc

Anthony Pompliano, founder and CEO of Professional Capital Management, discussed the rise of branded &#8220;meme coins&#8221; like those tied to <a href="https://www.benzinga.com/money/trump-coin-price-prediction">Donald and Melania Trump</a>.
What Happened: Speaking with CNBC on <a href="https://www.youtube.com/watch?v=t_2I5B26DbA">Tuesday</a>, Pompliano likened meme coins to digital trading cards—speculative assets with value primarily driven by branding and perceived scarcity rather than underlying business fundamentals.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>Since Launch</td>
</tr>
<tr>
<td>OFFICIAL TRUMP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">TRUMP</a>)</td>
<td>&nbsp;$39.52</td>
<td>$7.9 billion</td>
<td>+2.9%&nbsp;</td>
<td>+509.4%&nbsp;</td>
</tr>
<tr>
<td>Official Melania Meme (CRYPTO: MELANIA)</td>
<td>&nbsp;$3.79</td>
<td>$728.3 million</td>
<td>-0.3%&nbsp;</td>
<td>-48.2%&nbsp;</td>
</tr>
</tbody>
</table>
</figure>
Commenting on Trump and Melania Coins, he described them as examples of leveraging strong personal brands in the digital financial space. 
He noted that Trump's track record in business and his widely recognized personal brand amplify investor interest, even amid concerns about the coins&#8217; financial foundation or potential conflicts of interest.
Pompliano explained that perceived scarcity often contributes to the value of these coins, much like Bitcoin or rare art, but their speculative nature makes them highly volatile. 
He urged investors to critically assess the long-term value of such assets.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43133561/bitcoin-could-drop-up-to-20-as-trump-hope-fades-standard-chartered-warns">Bitcoin Could Drop Up To 20% As Trump &#8216;Hope&#8217; Fades, Standard Chartered Warns</a>
Why It Matters: Pompliano highlighted how retail investors play a pivotal role in propelling these assets, much like Dogecoin's (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) meteoric rise despite its origins as a joke. 
He contrasted this retail enthusiasm with institutional acceptance of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), which has gained legitimacy as a digital asset.
However, he cautioned that meme coins, including Trump-themed tokens, lack tangible business backing and pose significant investment risks. 
Critics, such as Dave Portnoy, have likened some meme coins to Ponzi schemes, further emphasizing the need for caution
Pompliano also highlighted Bitcoin&#8217;s <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42815711/bitcoin-is-the-the-grand-daddy-and-outshines-wall-street-anthony-pompliano-says">dominance as a legitimate investment</a>, noting its superior performance compared to traditional assets like the S&amp;P 500, gold and Berkshire Hathaway.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/43135463/strategic-bitcoin-reserve-probability-up-to-64-despite-trump-silence-on-crypto">Strategic Bitcoin Reserve Probability Up To 64% Despite Trump Silence On Crypto</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

$DOGE

$TRUMP

Donald, Melania Trump Meme Coins Are A Personal Brand Play, Says Anthony Pompliano

RBC Capital analyst Trevor Bryan reiterates Northland Power (TSX:<a class="ticker" href="https://www.benzinga.com/stock/NPI#TSX">NPI</a>) with a Outperform and maintains C$28 price target.

Price Target

Reiteration

Analyst Ratings

TSX:NPI

RBC Capital Reiterates Outperform on Northland Power, Maintains C$28 Price Target

In the current session, the stock is trading at $20.83, after a 1.26% spike. Over the past month, Plains All American Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAA#NASDAQ">PAA</a>) stock increased by 23.69%, and in the past year, by 29.86%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1737569711_0.png" alt="Past Year Chart" />

<h3>Plains All American P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 32.73 in the Oil, Gas &amp; Consumable Fuels industry, Plains All American Inc. has a lower P/E ratio of 18.2. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1737569711_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Plains All American

On Tuesday, <a target="_blank" href="https://www.cnbc.com/2025/01/21/jim-crame-taiwan-semis-bullish-earnings-revives-optimism.html" rel="noreferrer noopener">CNBC&#8217;s&nbsp;Jim Cramer</a> called out the market reaction to Taiwan Semiconductor Manufacturing Co&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) <a target="_blank" href="https://www.benzinga.com/government/regulations/25/01/43099745/taiwan-semiconductor-touts-1-5-billion-in-us-subsidies-confident-trump-will-maintain-chips-act-backing" rel="noreferrer noopener">quarterly print</a>. The sector, especially capital equipment companies, got a boost from the chipmaker&#8217;s report and guidance.
Taiwan Semiconductor reported&nbsp;fourth-quarter revenue&nbsp;of $26.88 billion, up by 39%, topping the analyst consensus of $26.28 billion.
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/price-target/25/01/43110913/apples-iphone-dependence-remains-but-services-wearables-offer-growth-potential-analyst" rel="noreferrer noopener">Apple&#8217;s iPhone Dependence Remains, But Services, Wearables Offer Growth Potential: Analyst</a>
The gross margin was 59%, up 600 bps, backed by its 3-nm and 5-nm technologies.
The company expects first-quarter 2025 revenue of $25.0 billion—$25.8 billion, compared to the&nbsp;$24.97 billion consensus estimate. It has also earmarked $38 billion—$42 billion in fiscal 2025 capex versus the actual fiscal 2024 capex of $29.8 billion.&nbsp;
Taiwan Semiconductor shared plans to boost manufacturing capabilities, marking its focus on advanced process technologies.
Cramer correlated advanced process technologies with equipment catering to Nvidia Corp&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) GPUs and other accelerators. Taiwan Semiconductor&#8217;s plan to boost capex on equipment triggered a rally in its supplier stocks, including&nbsp;Applied Materials, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMAT#NASDAQ">AMAT</a>),&nbsp;Lam Research&nbsp;Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>), and&nbsp;KLA Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>), Cramer reasoned. However, the rally reflected investor conviction on the companies&#8217; prospects.
Cramer also attributed the rally to investor expectations that the Trump administration would soften some of the Biden government&#8217;s advanced semiconductor technology embargo as the former took charge on Monday.
Taiwan Semiconductor won a $1.5 billion grant from the U.S. for its semiconductor facilities in Arizona, where the chipmaker has invested over $65 billion.
Trump verbally attacked Taiwan Semi during&nbsp;<a target="_blank" href="https://www.benzinga.com/25/01/43053982/taiwan-semiconductor-chief-calls-us-semiconductor-sanctions-manageable-to-skip-trump-inauguration" rel="noreferrer noopener">his presidential campaign</a> for allegedly&nbsp;undermining America&#8217;s chip industry. He also criticized the U.S. CHIPS Act and promised to slap tariffs on Taiwanese chips.
Recently, Taiwan Semiconductor chief C.C. Wei dismissed concerns over U.S. AI sanctions, calling them &#8220;manageable.&#8221; He voiced the chipmaker&#8217;s focus on advanced packaging, citing that non-AI sectors like automotive and crypto mining remain unaffected by sanctions.
Bernstein analyst Rupal Agarwal reiterated an Outperform rating on Taiwan Semiconductor with a $258.00 price target, marking it as the firm&#8217;s 2025 top pick.
Taiwan Semiconductor stock surged over 93% in the last 12 months.
Price Action: TSM stock traded higher by 2.41% to $223.97 at the last check on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/25/01/43065280/intel-gains-8-on-speculation-of-buyout-details-remain-unclear" target="_blank" rel="noreferrer noopener">Intel Stock Gains On Speculative Buyout Report, Details Remain Unclear</a></li>
</ul>
Photo by wakamatsu.h via Shutterstock

Tech

Media

Trading Ideas

AMAT

KLAC

LRCX

NVDA

Taiwan Semiconductor's Capex Plans Boost These Chip Stocks, Jim Cramer Says

Tech stocks enjoyed a surge Wednesday, driven by a sharp rise in semiconductor shares after President Donald Trump, OpenAI's Sam Altman, Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) co-founder Larry Ellison, and SoftBank CEO Masayoshi Son unveiled the <a href="https://www.benzinga.com/etfs/sector-etfs/25/01/43135764/trumps-500-billion-stargate-ai-plan-puts-3-etfs-in-focus">Stargate Project on Tuesday</a>.
The $500 billion initiative is set to develop AI infrastructure in the U.S. over the next four years.
According to OpenAI, &#8220;this infrastructure will secure American leadership in AI, create hundreds of thousands of American jobs, and generate massive economic benefit for the entire world.&#8221;
The iShares Semiconductor ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOXX#NASDAQ">SOXX</a>) was up 2.3% by midday trading in New York, eyeing their fourth straight positive session, the longest streak since late September. 
Yet, Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)&#8217;s CEO Elon Musk questioned the financial viability, saying that founders &#8220;<a href="https://www.benzinga.com/markets/equities/25/01/43121798/elon-musk-says-project-stargate-doesnt-actually-have-the-money-after-trump-announces-500-billion-ai-investment-led-by-softbank-oracle-and-openai">don't actually have the money</a>.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">They don't actually have the money
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1881923570458304780?ref_src=twsrc%5Etfw">January 22, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The earnings season continues to be off to a strong start, with companies surpassing fourth-quarter expectations, showcasing the resilience of corporate America. Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) delivered a stronger-than-expected quarterly performance across the board, driving its shares up 12%.
Elsewhere, small caps paused for a breather following Tuesday&#8217;s outperformance vis-à-vis large-cap counterparts. 
Chinese stocks slipped, with the iShares China Large-Cap ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXI#NYSE">FXI</a>) down 0.8%, after Trump floated the idea of imposing a 10% tariff on China starting from Feb. 1.
In commodities, gold prices surged to an 11-week-high, marking their tenth gain in the past eleven sessions, as investors flocked to safe-haven assets amid rising geopolitical risks.
On Wednesday, Trump warned Russian President Vladimir Putin of potential new sanctions if a peace deal for Ukraine is not reached. Meanwhile, oil prices remained flat after three consecutive sessions of losses.
In the crypto market, selling pressure is mounting as traders react to the absence of crypto-related commentary from the new administration, which had previously positioned itself as crypto-friendly. Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) retreated nearly 2% to $104,000.
<h3 class="wp-block-heading">Wednesday&#8217;s Performance In Major US Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %chg</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>21,933.62</td>
<td>1.7%</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>6,103.81</td>
<td>0.9%</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>44,173.70</td>
<td>0.3%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,307.01</td>
<td>-0.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:30 p.m. ET</figcaption></figure>
According to&nbsp;<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent012225&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Benzinga Pro</a>&nbsp;data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) rose 0.8% to $602.64.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.3% higher to $441.25.</li>
<li>The tech-heavy&nbsp;Invesco QQQ Trust Series&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) rallied 1.6% to $533.22.</li>
<li>The&nbsp;iShares Russell 2000 ETF&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.5% to $228.56.</li>
<li>The&nbsp;Technology Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>) rallied, up 2.4%; the&nbsp;Utilities Select Sector SPDR Fund&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>) lagged, down 1.6%.</li>
</ul>
<h3 class="wp-block-heading">Wednesday&#8217;s Stock Movers</h3>
<ul>
<li>Oracle Corp. rallied 7% as reaction to the Stargate project. Arm Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) was the chipmaker&#8217;s top performer on Wednesday, up 14%. Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) rose over 4%. </li>
<li>Procter &amp; Gamble Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PG#NYSE">PG</a>) rose 2.8% in reaction to quarterly results beating Street&#8217;s estimates. </li>
<li>Other stocks reacting to company earnings include Interactive Brokers Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>), up 8.8%, Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>), up 2.6%, United Airlines Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>), down 2%, Seagate Technology Holdings plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>), up 9%, Bank of America Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), down 1.3%, Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) down 3.4%, Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>), up 2.2%, GE Vernova Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GEV#NYSE">GEV</a>), up 2.2%, Amphenol Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APH#NYSE">APH</a>), up 6%, The Travelers Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>) up 3.8%, Halliburton Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HAL#NYSE">HAL</a>), down 1.3%, Ally Financials Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALLY#NYSE">ALLY</a>), up 4.5%. </li>
<li>Major large-cap companies slated to report earnings after the close include Kinder Morgan Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMI#NYSE">KMI</a>), Discover Financial Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DFS#NYSE">DFS</a>) and Steel Dynamics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STLD#NASDAQ">STLD</a>), </li>
</ul>
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/news/global/25/01/43135622/coffee-prices-soar-to-record-highs-could-starbucks-face-margin-squeeze">Coffee Prices Soar To Record Highs: Could Starbucks Face Margin Squeeze?</a></li>
</ul>
Image: Shutterstock

Earnings

Equities

Government

Large Cap

Mid Cap

Regulations

Sector ETFs

Broad U.S. Equity ETFs

Commodities

Small Cap

ETFs

ALLY

SPDR Dow Jones Industrial Average ETF Trust

IBKR

NFLX

ORCL

iShares PHLX SOX Semiconductor Sector Index Fund

SOXX

STLD

TSLA

Chipmakers Rally On AI Stargate Bet, Netflix Soars, Bitcoin Falters As Trump Keeps Quiet On Crypto: What's Driving Markets Wednesday?

Bank of America analyst Lorraine Hutchinson reiterated a Buy rating on Bath &amp; Body Works, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBWI#NYSE">BBWI</a>) and maintained its $45 price target.
The Details: Hutchinson, in the note, explains that investors are often concerned that Average Unit Retail (AUR) will weaken as the company relies on promotions to drive sales.
However, the analyst argues that Bath &amp; Body Works will continue using a mix of strategies in 2025 to generate positive conversion trends and modest AUR growth. In the past, the company has used strategic price increases on fragrances, higher traffic through store remodels, and a mix of other methods to achieve this.
The analyst believes positive growth will continue due to the company&#8217;s Netflix collaboration and new product launches. Specifically, Hutchinson highlights the launch of new adjacencies, including Men's, Hair, Lip and Laundry.
Among these new categories, Men's grooming stands out as the largest. Despite its relatively low awareness, it demonstrates strong potential driven by early momentum from increased marketing and a new fragrance launch in the third quarter.
The analyst also believes that candle sales, which spiked during COVID and then tapered off as trends normalized, will no longer hinder Bath &amp; Body Works' overall sales. Although candle sales have yet to return to pre-COVID growth levels, the decline has slowed, and the analyst does not expect it to negatively impact 2025 sales.
Related Link: <a href="https://www.benzinga.com/news/contracts/25/01/43137464/rail-vision-shares-surge-after-sujan-ventures-agrees-to-advance-safety-systems">Rail Vision Shares Surge After Sujan Ventures Agrees To Advance Safety Systems</a>
BBWI Price Action: At the time of writing, Bath &amp; Body Works shares are trading 0.4% lower at $37.12, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Courtesy of Bath &amp; Body Works, Inc.

Movers

BBWI

Hutchinson Maintains Buy Rating On Bath & Body Works, Sees Continued Growth

RBC Capital analyst Karl Shepard maintains Zions Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>) with a Sector Perform and raises the price target from $61 to $63.

ZION

RBC Capital Maintains Sector Perform on Zions Bancorp, Raises Price Target to $63

Macro Economic Events

Economics

North Dakota Oil Output Estimated To Be Down About 70,000-100,000 BPD Due To Extreme Cold And Related Operations Challenges; North Dakota Pipeline Authority Anticipate That The Majority Of The Lost Production Will Return Online Within The Next 3-6 Days

RBC Capital analyst Karl Shepard reiterates Old National (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONB#NASDAQ">ONB</a>) with a Sector Perform and raises the price target from $24 to $26.

RBC Capital Reiterates Sector Perform on Old National, Raises Price Target to $26

RBC Capital analyst Nik Modi reiterates Monster Beverage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNST#NASDAQ">MNST</a>) with a Outperform and maintains $59 price target.

MNST

RBC Capital Reiterates Outperform on Monster Beverage, Maintains $59 Price Target

<a href="https://news.delta.com/delta-teams-working-recover-day-after-rare-gulf-coast-region-snow-event" title="https://news.delta.com/delta-teams-working-recover-day-after-rare-gulf-coast-region-snow-event">https://news.delta.com/delta-teams-working-recover-day-after-rare-gulf-coast-region-snow-event</a>

Delta Air Lines Canceled About 400 Delta Mainline & Delta Connection Flights Before Noon Wednesday Due To Gulf Coast Region Snow; Says Customers Should Anticipate Additional Delays & Cancellations

Susquehanna analyst Christopher Rolland maintains Ambarella (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMBA#NASDAQ">AMBA</a>) with a Positive and raises the price target from $95 to $100.

AMBA

Susquehanna Maintains Positive on Ambarella, Raises Price Target to $100

Atmos Energy's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATO#NYSE">ATO</a>) short percent of float has fallen 10.9% since its last report. The company recently reported that it has 4.43 million shares sold short, which is 3.27% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.35 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Atmos Energy Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737568933_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Atmos Energy has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Atmos Energy's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Atmos Energy's peer group average for short interest as a percentage of float is 3.22%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

How Is The Market Feeling About Atmos Energy?

RCI Hospitality Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RICK#NASDAQ">RICK</a>) today announced closing on the acquisition of Flight Club, the premier gentlemen's club in the Detroit market, 5 miles from Detroit Metro Airport and 20 miles from downtown, casinos and major sports venues.
The purchase price totaled $11.0 million, consisting of $3.0 million cash and $5.0 million seller financing at 8.0% for the club, and $3.0 million cash for associated real estate. The company expects the acquisition to contribute an estimated $2.0 million in annualized adjusted EBITDA.

RICK

RCI Hospitality Announces $11M Acquisition Of Flight Club In Detroit; Expected $2M Annualized EBITDA Contribution

Susquehanna analyst Chris Rolland maintains ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Neutral and raises the price target from $118 to $140.

Susquehanna Maintains Neutral on ARM Holdings, Raises Price Target to $140

Williams Companies's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMB#NYSE">WMB</a>) short percent of float has risen 4.46% since its last report. The company recently reported that it has 17.88 million shares sold short, which is 1.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.71 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Williams Companies Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737568928_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Williams Companies has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Williams Companies's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Williams Companies's peer group average for short interest as a percentage of float is 4.34%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(WMB) - Analyzing Williams Companies's Short Interest

4 analysts have shared their evaluations of Hancock Whitney (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HWC#NASDAQ">HWC</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $71.0, a high estimate of $74.00, and a low estimate of $68.00. This upward trend is evident, with the current average reflecting a 9.23% increase from the previous average price target of $65.00.
<img src="https://www.benzinga.com/files/images/story/2025/1737568925_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Hancock Whitney. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Rose</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Strong Buy</td>
<td>$72.00</td>
<td>$64.00</td>
</tr>
<tr>
<td>Matt Olney</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$74.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Matt Olney</td>
<td>Stephens &amp; Co.</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$68.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Catherine Mealor</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$60.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Hancock Whitney. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Hancock Whitney compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Hancock Whitney's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Hancock Whitney's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/HWC/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Hancock Whitney analyst ratings.</a>
<h2>Delving into Hancock Whitney's Background</h2>
Hancock Whitney Corp operates bank offices and financial centers. The company offers a range of traditional and online banking services to commercial, small business and retail customers, providing a variety of transaction and savings deposit products, treasury management services, secured and unsecured loan products (including revolving credit facilities), letters of credit and similar financial guarantees. The Bank provides trust and investment management services to retirement plans, corporations and individuals and provides its customers access to investment advisory and brokerage products.
<h3>Hancock Whitney: A Financial Overview</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: Hancock Whitney displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 3.05%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Financials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Hancock Whitney's net margin is impressive, surpassing industry averages. With a net margin of 31.48%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.84%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Hancock Whitney's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.33%, the company showcases efficient use of assets and strong financial health.
Debt Management: Hancock Whitney's debt-to-equity ratio is below the industry average. With a ratio of 0.2, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>What Are Analyst Ratings?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 4 Analysts Discuss Hancock Whitney Stock

Pinnacle West Capital's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PNW#NYSE">PNW</a>) short percent of float has fallen 14.11% since its last report. The company recently reported that it has 3.50 million shares sold short, which is 3.53% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.4 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Pinnacle West Capital Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1737568923_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Pinnacle West Capital has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Pinnacle West Capital's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Pinnacle West Capital's peer group average for short interest as a percentage of float is 2.15%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into Pinnacle West Capital's Recent Short Interest

In the latest quarter, 7 analysts provided ratings for Eagle Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXP#NYSE">EXP</a>), showcasing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Eagle Materials, presenting an average target of $310.29, a high estimate of $330.00, and a low estimate of $280.00. Highlighting a 0.87% decrease, the current average has fallen from the previous average price target of $313.00. 
<img src="https://www.benzinga.com/files/images/story/2025/1737568917_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Eagle Materials. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Trey Grooms</td>
<td>Stephens &amp; Co.</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$310.00</td>
<td>$325.00</td>
</tr>
<tr>
<td>Anthony Pettinari</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$280.00</td>
<td>$334.00</td>
</tr>
<tr>
<td>Philip Ng</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$310.00</td>
<td>$330.00</td>
</tr>
<tr>
<td>Adrian Huerta</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$310.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Garik Shmois</td>
<td>Loop Capital</td>
<td>Maintains</td>
<td>Hold</td>
<td>$315.00</td>
<td>$315.00</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$330.00</td>
<td>$320.00</td>
</tr>
<tr>
<td>Jerry Revich</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$317.00</td>
<td>$277.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Eagle Materials. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Eagle Materials compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Eagle Materials's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Eagle Materials's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EXP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Eagle Materials analyst ratings.</a>
<h2>Delving into Eagle Materials's Background</h2>
Eagle Materials Inc produces and sells construction products and building materials. Construction products include cement, slag, concrete, and aggregates and building materials include cement and gypsum wallboard, and are sold to the construction and building industries. The firm organizes itself into two sectors: Heavy Materials, which includes the Cement and Concrete and Aggregates segments, and Light Materials, which includes the Gypsum Wallboard and Recycled Paperboard segments.
<h3>Eagle Materials's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Eagle Materials's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 0.22%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Net Margin: Eagle Materials's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 23.01%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Eagle Materials's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 10.32%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Eagle Materials's ROA excels beyond industry benchmarks, reaching 4.66%. This signifies efficient management of assets and strong financial health.
Debt Management: Eagle Materials's debt-to-equity ratio is notably higher than the industry average. With a ratio of 0.77, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Basics of Analyst Ratings</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

7 Analysts Assess Eagle Materials: What You Need To Know

Susquehanna analyst Mehdi Hosseini maintains KLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLAC#NASDAQ">KLAC</a>) with a Neutral and raises the price target from $620 to $655.

Susquehanna Maintains Neutral on KLA, Raises Price Target to $655

Analyst Debanjana Chatterjee from JonesTrading reiterated a Buy rating on Clearside Biomedical (CLSD – Research Report) and keeping the price targe...

Clearside Biomedical's CLS-AX Shows Promising Phase 2b Results for Wet AMD, Justifying a Buy Rating with a $6.00 Target

Clearside Biomedical (CLSD) announced that multiple presentations were delivered at the 2024 Annual Meeting of the American Academy of Ophthalmolog...

Clearside Biomedical announces multiple presentations delivered at 2024 AAO

Clearside Biomedical GAAP EPS of -$0.10 beats by $0.02, revenue of $1.03M beats by $0.91M

Reports Q3 revenue $1.04M, consensus $120,000. "We are making outstanding progress advancing our differentiated suprachoroidal delivery pipeline," ...

Clearside Biomedical reports Q3 EPS (10c), consensus (12c)

Clearside Biomedical, Inc. (CLSD) Q3 2024 Earnings Conference Call Transcript

Clearside Biomedical Inc ( ($CLSD) ) has released its Q3 earnings. Here is a breakdown of the information Clearside Biomedical Inc presented to its...

Clearside Biomedical Reports Positive Q3 2024 Results

Clearside Biomedical (CLSD – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Debanjana Chatt...

Promising Outlook for Clearside Biomedical: Buy Rating Backed by Strong Phase 2b ODYSSEY Trial Data and Robust Cash Position

Clearside Biomedical (CLSD) announced that presentations highlighting Clearside's suprachoroidal delivery technology and data on its pipeline progr...

Clearside extends global footprint with presentations at medical meetings

Clearside Biomedical ( ($CLSD) ) has issued an announcement. Clearside Biomedical has updated its corporate presentation to highlight its advanceme...

Clearside Biomedical Highlights Advancements in Drug Delivery

Clearside Biomedical (CLSD) announced that the official journal of The Royal College of Ophthalmologists, Eye, published a summary of critical insi...

Clearside announces publication of insights on drug development, regulation

CLSD

Health Care

Press Releases

Clearside Biomedical Announces Positive Topline Results from ODYSSEY Phase 2b Trial of Suprachoroidal CLS-AX in Wet AMD Achieving All Primary and Secondary Outcomes

Clearside Biomedical's Positive ODYSSEY Wet AMD Data and Suprachoroidal Injection Platform Highlighted in Presentations at Multiple Events During AAO 2024 Annual Meeting

Clearside Biomedical to Report Third Quarter 2024 Financial Results and Provide Corporate Update on Tuesday, November 12, 2024

Management

Clearside Biomedical Appoints Tony Gibney as New Chair of the Board of Directors

Clearside Biomedical to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference

Clearside Biomedical Partner Arctic Vision Executes Commercial Collaboration Agreement with Santen Pharmaceutical Co., Ltd for ARVN001 Suprachoroidal Space Injection Therapy for the Treatment of Uveitic Macular Edema

Clearside Biomedical Announces Third Quarter 2024 Financial Results and Provides Corporate Update

Clearside Biomedical Extends Global Footprint with Numerous Presentations at Medical Meetings in Asia, Europe and the United States

General

Clearside Biomedical Announces Publication of Critical Insights into Retinal Drug Development in the Peer-Reviewed Scientific Journal, Eye

Clearside Biomedical Announces its Asia-Pacific Partner, Arctic Vision, Received Approval of Suprachoroidal Treatment for Uveitic Macular Edema in Australia and Singapore

Comments

Clearside Biomedical

뉴스

에 대한 최신 뉴스 Clearside Biomedical (NASDAQ:CLSD) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌